276 related articles for article (PubMed ID: 30111182)
1. Latest advances in diagnosing and predicting DILI: what was new in 2017?
Barnhill MS; Real M; Lewis JH
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1033-1043. PubMed ID: 30111182
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced liver injury: recent advances in diagnosis and risk assessment.
Kullak-Ublick GA; Andrade RJ; Merz M; End P; Benesic A; Gerbes AL; Aithal GP
Gut; 2017 Jun; 66(6):1154-1164. PubMed ID: 28341748
[TBL] [Abstract][Full Text] [Related]
3. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
Church RJ; Kullak-Ublick GA; Aubrecht J; Bonkovsky HL; Chalasani N; Fontana RJ; Goepfert JC; Hackman F; King NMP; Kirby S; Kirby P; Marcinak J; Ormarsdottir S; Schomaker SJ; Schuppe-Koistinen I; Wolenski F; Arber N; Merz M; Sauer JM; Andrade RJ; van Bömmel F; Poynard T; Watkins PB
Hepatology; 2019 Feb; 69(2):760-773. PubMed ID: 29357190
[TBL] [Abstract][Full Text] [Related]
4. MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury.
Howell LS; Ireland L; Park BK; Goldring CE
Expert Rev Mol Diagn; 2018 Jan; 18(1):47-54. PubMed ID: 29235390
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Systems Toxicology Approaches to Understand and Predict Drug-Induced Liver Injury.
Watkins PB
Clin Liver Dis; 2020 Feb; 24(1):49-60. PubMed ID: 31753250
[TBL] [Abstract][Full Text] [Related]
6. Latest advances in predicting DILI in human subjects: focus on biomarkers.
Hawkins MT; Lewis JH
Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1521-30. PubMed ID: 22998122
[TBL] [Abstract][Full Text] [Related]
7. Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury.
Shi Q; Yang X; Mendrick DL
Biomark Med; 2013 Apr; 7(2):307-15. PubMed ID: 23547824
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
Aithal GP
Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.
McGill MR; Jaeschke H
Expert Rev Mol Diagn; 2018 Sep; 18(9):797-807. PubMed ID: 30080986
[TBL] [Abstract][Full Text] [Related]
10. The transformation in biomarker detection and management of drug-induced liver injury.
Church RJ; Watkins PB
Liver Int; 2017 Nov; 37(11):1582-1590. PubMed ID: 28386997
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury.
Grant LM; Rockey DC
Curr Opin Gastroenterol; 2012 May; 28(3):198-202. PubMed ID: 22450893
[TBL] [Abstract][Full Text] [Related]
12. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
13. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
Church RJ; Watkins PB
Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
[TBL] [Abstract][Full Text] [Related]
14. Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
Russo MW; Steuerwald N; Norton HJ; Anderson WE; Foureau D; Chalasani N; Fontana RJ; Watkins PB; Serrano J; Bonkovsky HL
Liver Int; 2017 May; 37(5):757-764. PubMed ID: 27860186
[TBL] [Abstract][Full Text] [Related]
15. Drug-Induced Liver Injury: Highlights of the Recent Literature.
Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
[TBL] [Abstract][Full Text] [Related]
16. Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?
Shahbaz O; Mahajan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):935-951. PubMed ID: 28772086
[TBL] [Abstract][Full Text] [Related]
17. Highlights of the drug-induced liver injury literature for 2021.
Woo SM; Alhaqqan DM; Gildea DT; Patel PA; Cundra LB; Lewis JH
Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):767-785. PubMed ID: 35839342
[TBL] [Abstract][Full Text] [Related]
18. Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.
Krauskopf J; Caiment F; Claessen SM; Johnson KJ; Warner RL; Schomaker SJ; Burt DA; Aubrecht J; Kleinjans JC
Toxicol Sci; 2015 Feb; 143(2):268-76. PubMed ID: 25359176
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity.
Umbaugh DS; Jaeschke H
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):363-375. PubMed ID: 33242385
[No Abstract] [Full Text] [Related]
20. A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats.
Su YW; Chen X; Jiang ZZ; Wang T; Wang C; Zhang Y; Wen J; Xue M; Zhu D; Zhang Y; Su YJ; Xing TY; Zhang CY; Zhang LY
PLoS One; 2012; 7(5):e37395. PubMed ID: 22624025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
